Last reviewed · How we verify

NCT03442322

Optimizing Care for Patients With Dementia

Completed NA Results posted Last updated 19 August 2024
What this trial tests

NA trial testing transdisciplinary approach in Alzheimer Disease in 53 participants. Completed in 26 July 2022.

Timeline
15 March 2018
Primary endpoint
26 July 2022
26 July 2022

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposehealth services research
Enrollment53
Start date15 March 2018
Primary completion26 July 2022
Estimated completion26 July 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

Eligibility, any sex, with Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Dispensing of Psychotropic Medications Primary · 6-month period (months 1-6)

Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 1-6 of Intervention.

GroupValue95% CI
Transdisciplinary Approach161
Multidisciplinary Approach315
Dispensing of Psychotropic Medications Primary · 12-month period (months 7-12)

Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 7-12 of Intervention.

GroupValue95% CI
Transdisciplinary Approach125
Multidisciplinary Approach289
Dispensing of Psychotropic Medications Primary · 18-month period (months 13-18)

Percentage of nursing home residents with dementia who received one or more antipsychotic medication over Months 13-18 of Intervention.

GroupValue95% CI
Transdisciplinary Approach107
Multidisciplinary Approach227
Behavioral Symptoms Primary · 6-month period (months 1-6)

Percentage of nursing home residents with dementia who had behavioral symptoms over Months 1-6 of Intervention.

GroupValue95% CI
Transdisciplinary Approach143
Multidisciplinary Approach334
Behavioral Symptoms Primary · 12-month period (months 7-12)

Percentage of nursing home residents with dementia who had behavioral symptoms over Months 7-12 of Intervention.

GroupValue95% CI
Transdisciplinary Approach104
Multidisciplinary Approach299
Behavioral Symptoms Primary · 18-month period (months 13-18)

Percentage of nursing home residents with dementia who had behavioral symptoms over Months 13-18 of Intervention.

GroupValue95% CI
Transdisciplinary Approach68
Multidisciplinary Approach232
Wandering Primary · 6-month period (months 1-6)

Percentage of nursing home residents with dementia who had wandering over Months 1-6 of Intervention.

GroupValue95% CI
Transdisciplinary Approach88
Multidisciplinary Approach117
Wandering Primary · 12-month period (months 7-12)

Percentage of nursing home residents with dementia who had wandering over Months 7-12 of Intervention.

GroupValue95% CI
Transdisciplinary Approach52
Multidisciplinary Approach116
Wandering Primary · 18-month period (months 13-18)

Percentage of nursing home residents with dementia who had wandering over Months 13-18 of Intervention.

GroupValue95% CI
Transdisciplinary Approach38
Multidisciplinary Approach98
Rejection of Care Primary · 6-month period (months 1-6)

Percentage of nursing home residents with dementia who had rejection of care over Months 1-6 of Intervention.

GroupValue95% CI
Transdisciplinary Approach131
Multidisciplinary Approach302
Rejection of Care Primary · 12-month period (months 7-12)

Percentage of nursing home residents with dementia who had rejection of care over Months 7-12 of Intervention.

GroupValue95% CI
Transdisciplinary Approach75
Multidisciplinary Approach282
Rejection of Care Primary · 18-month period (months 13-18)

Percentage of nursing home residents with dementia who had rejection of care over Months 13-18 of Intervention.

GroupValue95% CI
Transdisciplinary Approach59
Multidisciplinary Approach217

Sponsor's own description

Of the 1.4 million nursing home (NH) residents in long term care facilities, more than half have Alzheimer's disease or dementia. Due to changes in their familiar daily routines, difficulty expressing their thoughts or asking for what they need, and overstimulation (such as noise) or under stimulation (such as lack of activity), individuals with dementia often display disruptive behaviors like resisting help or continually repeating the same phrases. Medications are often prescribed to reduce agitation and aggressive behavior; however, these medications may not be effective and can have a negative impact on the individual. Therefore, families and other stakeholders strongly advocate the use of other types of approaches that focus on minimizing the cause of the behavior. Two facility-based methodologies include the transdisciplinary approach for integrated dementia care, which combines the expertise of all NH staff, who work together to build a common language and approach for each resident, and the multidisciplinary approach for problem-based dementia care, in which each staff member conducts individual assessments and makes discipline-specific recommendations. While prior research suggests that both of these facility-based approaches are useful, the circumstances under which each approach is most effective are not clear. This project will prospectively randomize 80 nursing homes to one of the two treatment arms to compare the effect of the transdisciplinary approach versus the multidisciplinary approach. This study will examine the difference between the two comparators with respect to facility rates of medications dispensed to residents with dementia, leading to enhanced quality of life for the resident. This project is important because it will address a key clinical dilemma NH staff face as they strive to optimize the use of alternative approaches to reduce disruptive behaviors in residents with dementia. Transforming the quality of dementia care in NHs and enhancing the quality of life of residents with dementia are high priorities for families and other advocates.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluating non-pharmacological approaches to nursing home dementia care: A protocol.
    Leland NE, Shier V, Piersol CV, Lekovitch C, et al · · 2023 · cited 4× · PMID 37347001 · DOI 10.1016/j.conctc.2023.101161

Verify or expand the search:

Other recruiting trials for Alzheimer Disease

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03442322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing